MASLD group:None

3 trials

Sponsors

The first affiliated hospital of dalian medical university, Zhongshan Hospital Fudan University, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Chronic hepatitis B, Metabolic dysfunction-associated steatotic liver diseaseChronic liver diseaseThe prevalence of metabolic associated fatty liver disease (MAFLD)/non-alcoholic fatty liver disease (NAFLD)

Early Phase 1

Impact of MASLD on hepatitis B virus infection, clinical outcomes, and prognosis — A prospective, multi-center, real-world study (Sail Plan).

Active, not recruitingChiCTR2400092651

The first affiliated hospital of dalian medical universityChronic hepatitis B, Metabolic dysfunction-associated steatotic liver disease

Start: 2024-11-30Updated: 2024-12-02

Unknown Phase

The Multi-Center Study on Quantitative Assessment of Diffuse Liver Disease Using Combined Ultrasonic Multimodal Imaging and Artificial Intelligence Algorithm

Active, not recruitingChiCTR2500109717

Zhongshan Hospital Fudan UniversityChronic liver disease

Start: 2025-10-15Updated: 2025-09-29

A prospective, multicenter, non-interventional observational study on novel non-invasive diagnostic markers for metabolic-associated fatty liver disease based on multiparametric magnetic resonance imaging combined with photon-counting CT.

Active, not recruitingChiCTR2600128144

Ruijin Hospital, Shanghai Jiao Tong University School of MedicineThe prevalence of metabolic associated fatty liver disease (MAFLD)/non-alcoholic fatty liver disease (NAFLD)

Start: 2026-07-15Updated: 2026-07-20